Tag: relapsing-remitting
Propuesta pionera de un marco nuevo para describir los tipos de esclerosis múltiple
Moving away from traditional clinical categories of MS may lead to better, and more personalised treatments for MS.
Cladribine approved in US for people with active secondary progressive MS
FDA approves cladribine for people with relapsing forms of MS and active secondary progressive MS
Resultados decepcionantes del ensayo de tratamiento para la CCSVI
Chronic Cerebrospinal Venous Insufficiency (CCSVI) describes a potential reduction in blood flow in the major veins that drain blood from the brain and spinal cord over a prolonged period.
Primer tratamiento autorizado para la EM progresiva primaria en los EE. UU.
Ocrelizumab has been approved as a treatment for both relapsing and primary progressive MS in the US